Fidelity Enhanced Mid Cap ETF(FMDE.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Fidelity Enhanced Mid Cap ETF
FMDE.US
News
View More

Ford is in talks with BYD to purchase batteries, with plans including "transporting to factories outside the United States."

According to reports, Ford is in deep discussions to procure batteries from BYD for some of its hybrid models. The proposals being explored by both parties include shipping the batteries to Ford's factories outside the United States, but the deal has not yet been finalized. As Ford reduces its pure electric vehicle business and increases its investment in hybrid models, the company urgently needs high-quality battery suppliers, and BYD has mature manufacturing capabilities in this field

Wallstreetcn·
US
F
-0.22%
US
BYDDY
+3.55%
US
BYDDF
+3.69%
Wallstreetcn·
US
F
-0.22%
US
BYDDY
+3.55%
US
BYDDF
+3.69%

Does Expanded Rapiblyk Distribution Hint at a Deeper Shift in Cardinal Health’s (CAH) Specialty Strategy?

AOP Health US, LLC has expanded access to its critical care drug Rapiblyk through Cardinal Health, reinforcing Cardinal's role in the specialty pharmaceutical supply chain. This distribution expansion supports Cardinal Health's investment narrative, projecting $288 billion in revenue and $2.2 billion in earnings by 2028. However, regulatory and reimbursement uncertainties remain key risks. Analysts have varying fair value estimates for Cardinal Health, indicating a wide range of expectations. The article emphasizes the importance of understanding these dynamics for potential investors.

Simplywall·
US
CAH
-0.05%
Simplywall·
US
CAH
-0.05%

Key facts: Cardinal Health raises earnings outlook; completes drug deals; launches diabetes program

Cardinal Health raised its fiscal 2026 earnings outlook to at least $10.00 per share, up from $9.65-$9.85, due to strong demand for specialty medicines and solid performance across its segments.123Cardinal Health has completed its transition of distribution agreements for all drugs affected by the 2026 Medicare price negotiations ahead of the year's start.4Cardinal Health launched the ContinuCare Pathway program to simplify diabetes supply management, with Publix Super Markets enrolling its entire network of nearly 1,400 pharmacies in the initiative.56

TradingView·
US
CAH
-0.05%
TradingView·
US
CAH
-0.05%

BUZZ-Cardinal Health gains after raising 2026 profit forecast

Shares of Cardinal Healthrose 2.7% to $208.1 in premarket trading after the company raised its 2026 adjusted profit forecast to at least $10 per share, up from the previous range of $9.65 to $9.85. Analysts had expected an annual profit of $9.83 per share. The company also anticipates revenue from specialty medicines to exceed $50 billion this year, indicating strong growth in key market areas. Shares have increased by 73.8% in 2025.

Reuters·
US
CAH
-0.05%
Reuters·
US
CAH
-0.05%

Cardinal Health Lifts FY26 Adj. Earnings View Above Market

Cardinal Health Inc. (CAH) has raised its fiscal 2026 adjusted earnings outlook to at least $10.00 per share, up from the previous range of $9.65 to $9.85, due to strong performance across its five operating segments. The company's shares rose by 1.3% in pre-market trading. Cardinal Health also projects Specialty revenues to exceed $50 billion in fiscal 2026, driven by robust demand and significant growth in BioPharma Solutions. Further details will be provided during the second quarter earnings call on February 5.

rttnews·
US
CAH
-0.05%
rttnews·
US
CAH
-0.05%
© 2026 Longbridge｜Disclaimer